NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 107 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,033 | -47.0% | 61,713 | +28.2% | 0.00% | – |
Q2 2023 | $124,703 | -67.5% | 48,148 | -48.8% | 0.00% | – |
Q1 2023 | $383,568 | +64.7% | 94,012 | +102.6% | 0.00% | – |
Q4 2022 | $232,903 | -99.6% | 46,395 | -98.9% | 0.00% | -100.0% |
Q3 2022 | $56,560,000 | +114.1% | 4,324,201 | +109.9% | 0.01% | +100.0% |
Q2 2022 | $26,416,000 | +36.0% | 2,060,533 | +61.8% | 0.00% | +50.0% |
Q1 2022 | $19,417,000 | -15.7% | 1,273,186 | -2.1% | 0.00% | 0.0% |
Q4 2021 | $23,043,000 | -16.2% | 1,301,138 | -0.5% | 0.00% | 0.0% |
Q3 2021 | $27,493,000 | +588.7% | 1,307,937 | +353.8% | 0.00% | – |
Q3 2019 | $3,992,000 | -5.4% | 288,200 | 0.0% | 0.00% | – |
Q2 2019 | $4,219,000 | – | 288,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |